Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 NBEs for MP and EP in urine derived from model simulations of an exposure to a NOEL under different scenarios likely to occur in children

From: Determination of no-observed effect level (NOEL)-biomarker equivalents to interpret biomonitoring data for organophosphorus pesticides in children

Exposure scenario used to derive the NBEs

Proposed NBE for methylphosphates in 12-h nighttime urine collectionsa

(nmol/kg bw)

Proposed NBE for ethylphosphates in 12-h nighttime urine collectionsb

(nmol/kg bw)

Ingestion of a bolus NOEL at dinnerc

106

87

Ingestion of 1/3 NOEL at each meald

127

52

8-h Dermal exposure to the NOELe

40

32

  1. a Corresponds to the total amounts of methylphosphate metabolites in 12-h nighttime collections (from 7:00 pm to 7:00 am) following different simulated NOEL exposure scenarios.
  2. b Corresponds to the total amounts of ethylphosphate metabolites in 12-h nighttime collections (from 7:00 pm to 7:00 am) following different simulated NOEL exposure scenarios.
  3. c Simulation of an oral exposure to the NOEL of either malathion or chlorpyrifos at 6:00 pm.
  4. d Simulation of an oral exposure to 1/3 of the NOEL of either malathion or chlorpyrifos at 7:00 am, noon and 6:00 pm.
  5. e Simulation of an 8-h dermal exposure to the NOEL of either malathion or chlorpyrifos starting 12 h prior to the onset of urine sampling.
Back to article page

Environmental Health

ISSN: 1476-069X